🔎 Trials Near Me

Home › Diffuse Intrinsic Pontine Glioma › District of Columbia › Washington

Diffuse Intrinsic Pontine Glioma clinical trials in Washington, DC

11 studies for Diffuse Intrinsic Pontine Glioma are looking for participants at sites in and around Washington (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

RecruitingPhase 2
  • Children's National Medical Center, Washington D.C.
12 Months – 39 Years · All sexes · Updated Sep 21, 2026 · NCT06838676

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

RecruitingPhase 1/2
  • Children's National Medical Center, Washington D.C.
12 Months – 21 Years · All sexes · Updated Sep 11, 2026 · NCT04870944

NgFUS NIVO: NeuroNavigation-Guided Focused Ultrasound With Nivolumab in Relapsed and Progressive DMG and Other High Grade Brain Tumors

RecruitingPhase 1
  • Children's National Hospital, Washington D.C.
Ages 3 to 25 · All sexes · Updated Sep 9, 2026 · NCT07664176

Targeted Pediatric High-Grade Glioma Therapy

RecruitingObservational study
  • Children's National Medical Center, Washington D.C.
12 Months – 39 Years · All sexes · Updated Sep 8, 2026 · NCT05839379

Study of Olutasidenib and Temozolomide in HGG

RecruitingPhase 2
  • Children's National Medical Center, Washington D.C.
Ages 12 to 39 · All sexes · Updated Sep 1, 2026 · NCT06161974

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

RecruitingPhase 2
  • Children's National Medical Center, Washington D.C.
Ages 3 to 39 · All sexes · Updated Aug 24, 2026 · NCT05096481

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

RecruitingEarly phase 1Healthy volunteers welcome
  • Children's National Medical Center, Washington D.C.
Ages 1 to 21 · All sexes · Updated Jun 29, 2026 · NCT06333899

Combination Therapy for the Treatment of Diffuse Midline Gliomas

RecruitingPhase 2
  • Children's National Hospital, Washington D.C.
Ages 2 to 39 · All sexes · Updated Jun 26, 2026 · NCT05009992

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

RecruitingPhase 2
  • Children's National Medical Center, Washington D.C.
12 Months – 39 Years · All sexes · Updated May 29, 2026 · NCT05843253

A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion

RecruitingEarly phase 1
  • Children's National Medical Center, Washington D.C.
Up to age 21 · All sexes · Updated Mar 18, 2026 · NCT04655404

Molecular Analysis of Samples From Patients With Diffuse Intrinsic Pontine Glioma and Brainstem Glioma

RecruitingObservational study
  • Children's National Medical Center, Washington D.C.
Up to age 21 · All sexes · Updated Aug 20, 2024 · NCT01106794

Diffuse Intrinsic Pontine Glioma trials in other cities

Other studies in Washington

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.